Hyperactivation of PAKs also supports cell survival over cell death [15], and the targeted depletion of PAK1, PAK2, or PAK4 in human cancer cell lines has been shown to compromise fitness and ability to survive [26,27] in a variety of cancer types (Figure 1C). This evidence concerns the gene PAK2 and cancer.